SAVA: Cassava Sciences Company Short-Term Debt
Cassava Sciences, Inc. (SAVA) is engaged in a high-risk battle against industry behemoths to develop an Alzheimer's therapy, where success hinges on final testing. The volume of short-term accounts payable and loans reflects the trend of liabilities, with the value holding at 0.00. Intellectual capital and patents form the basis for future revenues, while environmental policy is limited to the safe disposal of laboratory waste.
Metric breakdowns and analytics for Cassava Pharma (SAVA)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity details:
Debt to Equity Cassava Sciences, Inc.|SAVA - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Cassava Sciences, Inc.|SAVA - Company Total Debt Obligations|Debts to Book Capitalization Cassava Sciences, Inc.|SAVA - Company Long-Term Debts|Company Current Liabilities Cassava Sciences|Quick Ratio cassavasciences.com
- net income and valuation multiples indicators:
Fundamental company analysis:Cassava Sciences (SAVA)
The development of Simufilam and the maintenance of the patent perimeter require significant operating expenses, making liquidity critical for the functioning of the Cassava Sciences, Inc. (SAVA) biotechnological ecosystem. This metric aggregates all liabilities maturing within one year, measuring the company's ability to service debt without halting clinical protocols, while an analysis of short-term obligations allows for an assessment of default risk or capital shortages for expansion.
Competitors of Cassava Sciences, Inc. (SAVA)
BIIB - Company Short-Term Debt|Company Short-Term Loans and Borrowings NBIX (Neurocrine)|Regencell (RGC) - Company Short-Term Debt|Short-Term Debt Axsome Corp (AXSM)|ACAD (ACADIA Pharmaceuticals) - Company Short-Term Debts|Company Current Liabilities xenon-pharma.com (XENE)|Company Short-Term Debts VKTX|Company Short-Term Debts Supernus Pharmaceuticals, Inc. (SUPN)|Company Short-Term Debt Catalyst Pharmaceuticals Inc CPRX|Short-Term Debt Volume Denali Corp (DNLI)|HRMY - Company Short-Term Debt|Short-Term Debt Volume biohavenpharma.com BHVN|AMLX: Company Short-Term Debts|Trevi Therapeutics Inc (TRVI) - Company Short-Term Debts|Company Current Liabilities PRAX|Company Short-Term Debt AVXL|Company Short-Term Debts CBLL|Company Short-Term Debts Prothena Corporation plc (PRTA)|Alector - Company Current Liabilities|Company Short-Term Loans and Borrowings ANNX|OMER - Company Short-Term Debt|Short-Term Debt Volume Neurogene Therapeutics NGNE|ACIU: Company Short-Term Debts|Company Current Liabilities voyagertherapeutics.com|NMRA (Neumora Therapeutics, Inc.) - Company Short-Term Debts|Scilex Holding (SCLX) - Short-Term Debt Volume|Company Short-Term Debts TVGN|ACOG - Short-Term Debt|Company Short-Term Debt Cognition Therapeutics, Inc. CGTX|IKT: Company Short-Term Indebtedness|Assertio Therapeutics - Company Short-Term Debts|Coya Therapeutics, Inc. (COYA) - Company Current Liabilities|VTGN: Company Short-Term Debts|Short-Term Debt Ovid Therapeutics (OVID)|Company Short-Term Debt Acumen Pharmaceuticals|cervomed.com (CRVO) - Short-Term Debt Volume|Company Current Liabilities ATHE (Alterity Therapeutics)|CLNN (clene.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts PEPG (PepGen)|Short-Term Debt Volume jupiterneurosciences.com (JUNS)|RLMD - Company Short-Term Debt|ANVS (annovisbio.com) - Company Short-Term Indebtedness|GRCE: Company Short-Term Debts|Company Current Liabilities Firefly Neuroscience, Inc.|Company Current Liabilities KLTO|NeuroSense Therapeutics, Ltd. (NRSN) - Short-Term Debt Volume|Company Short-Term Debt Reviva Pharmaceuticals (RVPH)|Short-Term Debt Volume metaviatx.com|Company Short-Term Debts NRXS (NeurAxis)|Company Short-Term Debts Helius Medical Technologies, Inc. HSDT|PASG: Company Current Liabilities|NEUP: Company Short-Term Debt|NERV: Company Short-Term Debts|athira.com (ATHA) - Company Short-Term Debts|Company Short-Term Debt Addex Therapeutics Ltd|Company Short-Term Indebtedness ALZN (Alzamend)|Company Short-Term Debts CYCN|PTIX - Short-Term Debt|Pasithea Therapeutics Corp. - Company Current Liabilities|Company Short-Term Debts Cortigent Inc CRGT|ATXI - Company Short-Term Debt|Company Short-Term Loans and Borrowings BCLI (Brainstorm Cell Therapeutics Inc.)|Cara Therapeutics, Inc (CARA) - Company Short-Term Debt|Short-Term Debt Chromocell (CHRO)|ELYM (Eliem Therapeutics, Inc.) - Company Short-Term Debts|Company Current Liabilities Intra-Cellular (ITCI)|Company Short-Term Debts LBPH|Company Short-Term Debts Marinus Pharmaceuticals Inc (MRNS)|Company Short-Term Debt NKGen NKGN|Short-Term Debt Volume NeuroBo Pharma (NRBO)|SAGE - Company Short-Term Debt|Short-Term Debt Volume synaptogen.com SNPX|TRVN: Company Short-Term Debts|Vigil Neuroscience, Inc. (VIGL) - Company Short-Term Debts|Company Current Liabilities WENA|Company Short-Term Debt CERE